Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Harvard Business School
Covington
Farmers Insurance
QuintilesIMS
Cerilliant
Queensland Health
Chubb
Citi

Generated: February 21, 2018

DrugPatentWatch Database Preview

CORLANOR Drug Profile

« Back to Dashboard

When do Corlanor patents expire, and what generic alternatives are available?

Corlanor is a drug marketed by Amgen Inc and is included in one NDA. There are four patents protecting this drug.

This drug has ninety-five patent family members in forty-one countries.

The generic ingredient in CORLANOR is ivabradine hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ivabradine hydrochloride profile page.

US Patents and Regulatory Information for CORLANOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-001 Apr 15, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-002 Apr 15, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-001 Apr 15, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-002 Apr 15, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-001 Apr 15, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-001 Apr 15, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-002 Apr 15, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-001 Apr 15, 2015 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-002 Apr 15, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amgen Inc CORLANOR ivabradine hydrochloride TABLET;ORAL 206143-002 Apr 15, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for CORLANOR

Country Document Number Estimated Expiration
Slovenia 1707562 ➤ Sign Up
Norway 20060948 ➤ Sign Up
Saudi Arabia 2399 ➤ Sign Up
Australia 2006200856 ➤ Sign Up
Taiwan I314143 ➤ Sign Up
Japan 2006241156 ➤ Sign Up
Guatemala 200600084 ➤ Sign Up
Portugal 1695965 ➤ Sign Up
China 1827602 ➤ Sign Up
Austria 396974 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Dow
Merck
Healthtrust
Cerilliant
Queensland Health
Federal Trade Commission
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot